Ceramic Hydroxyapatite Column for dsRNA Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying mRNA are inefficient in removing double-stranded RNA (dsRNA) impurities, which can induce an immune response and reduce the efficacy of mRNA treatments, especially when scaling up to large batch sizes.
Innovation Solution
The use of a ceramic hydroxyapatite column with specific buffers, such as sodium phosphate, ethanol, and acetonitrile, to separate and elute single-stranded RNA, effectively reducing dsRNA impurities in the eluate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional purification methods (nuclease enzymes and purification columns) are used, then mRNA purification can be achieved, but the methods are difficult to scale up to large batch sizes and provide insufficient dsRNA removal
Solution Approach 1:
The patent applies parameter changes by systematically optimizing buffer composition (sodium phosphate concentration, ethanol percentage, acetonitrile concentration), pH values, and temperature conditions to achieve superior dsRNA removal efficiency while maintaining scalability to large batch sizes. The ceramic hydroxyapatite column operates under specific parameter ranges that maximize purification performance.
2Manufacturing precision
If traditional purification methods are used, then some purification can be achieved, but the yields are insufficient and purity including dsRNA removal is inadequate
Solution Approach 1:
The patent optimizes multiple parameters simultaneously including buffer composition (sodium phosphate at specific concentrations, ethanol percentages, acetonitrile concentrations), pH values, and temperature to achieve both high purity (superior dsRNA removal) and high yield. The ceramic hydroxyapatite column under optimized conditions provides superior purification performance without sacrificing productivity.
3Object-affected harmful factors
If current purification methods are used, then mRNA can be purified, but dsRNA impurities remain which can generate immune response and reduce treatment efficacy
Solution Approach 1:
The patent systematically optimizes buffer parameters including sodium phosphate concentration, ethanol percentage, and acetonitrile concentration to achieve superior dsRNA removal efficiency. The ceramic hydroxyapatite column operates under specific parameter ranges that minimize dsRNA impurities in the eluate, thereby reducing potential immune responses and enhancing treatment efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces dsRNA density in the eluate, achieving purities of less than 10% of the original load, enhancing the efficacy of mRNA treatments by minimizing immune responses and improving yield.
Implementation Method 1
loading the sample onto a ceramic hydroxyapatite column, washing the column with wash buffer, and eluting the column with an elution buffer
Data Source
AI summary
Provided herein are methods for purification of RNA from a sample. The methods include obtaining a first sample including double stranded RNA in a loading buffer, loading the sample onto a ceramic hydroxyapatite column, washing the column with wash buffer, and eluting the column with an elution buffer to create an eluate.